Health Care Equipment & Supplies · NYSE
ZBHZimmer Biomet Holdings, Inc.
- Last close
- $103.21 -1.3%
- 52-week range
- $79.12 to $112.55
- Market cap
- $19.5B
- Next earnings
- Not scheduled
Fiscal 2025 at a glance
Stock price
Valuation vs its own 10 years
Below its 10-year median on all 4 multiples
Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.
Key statistics
Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.
Valuation
- P/E
- 26.1x
- Earnings yield
- 3.8%
- Price / sales
- 2.3x
- Price / book
- 1.5x
- Price / operating cash flow
- 10.4x
- EV / EBITDA
- 11.7x
- EV / sales
- 3.1x
- Free cash flow yield
- 8.4%
Profitability
- Gross margin
- 69.7%
- Operating margin
- 13.6%
- Net margin
- 9.0%
- Return on equity
- 6.0%
- Return on capital
- 5.0%
Growth per year
- Revenue, 3 years
- +5.9%
- Revenue, 5 years
- +6.1%
- Revenue, 9 years
- +0.8%
- EPS, 3 years
- +47.8%
Balance sheet
- Cash and investments
- $400M
- Total debt
- $7.50B
- Net cash
- -$7.10B
- Debt / equity
- 0.59x
- Current ratio
- 1.46x
Shares and dividend
- Shares outstanding
- 189M
- Share count, 5 years
- -4.0%
- Beta, 1 year
- 0.40
- Dividend yield
- 0.9%
- Dividend per share, TTM
- $0.96
- Payout ratio
- 24.3%
Ten years of the business
Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.
Fiscal years 2016 to 2025.
Where the revenue comes from
Hips went from 27% to 25% of revenue in 3 years
Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.
| Product line | Revenue | Share | vs FY24 |
|---|---|---|---|
| Knees | $3.32B | 40.4% | +5% |
| SET | $2.15B | 26.1% | +15% |
| Hips | $2.09B | 25.4% | +5% |
| Technology and Data Bone Cement and Surgical | $666M | 8.1% | +4% |
Health Care Equipment & Supplies peers
The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.
| Company | Market cap | Revenue growth | Operating margin | P/E | P/S | P/E vs own history |
|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | $188B | +10% | 13.8% | 40.4x | 3.9x | 60th percentile |
| DHR Danaher Corp | $164B | +6% | 20.4% | 38.1x | 6.4x | 65th percentile |
| ISRG Intuitive Surgical Inc | $154B | +20% | 28.4% | 53.7x | 13.3x | 48th percentile |
| MDT Medtronic plc | $132B | +10% | 18.1% | 25.3x | 3.5x | 20th percentile |
| SYK Stryker Corp | $118B | +8% | 20.7% | 33.0x | 4.5x | 30th percentile |
| ZBH Zimmer Biomet Holdings, Inc. | $19.5B | +7% | 13.6% | 26.1x | 2.3x | 44th percentile |
The company
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Founded
- 1927
- Headquarters
- Warsaw, IN
- Fiscal year ends
- December
- Website
- zimmer.com
What it does
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
Description from Wikipedia (CC BY-SA).
Around the numbers
What the rest of EdgeStacker knows about ZBH.